Articles & White Papers

Day 0–2 (hospital). You'll be up and walking with a walker within 6–12 hours of surgery — that early mobilisation is what prevents blood clots and stiffness. Pain is real but manageable with the regional block and oral medications. Most patients sleep poorly the first two nights; that's normal.

Day 3–7 (early home recovery). You'll walk independently with the walker, manage stairs slowly with a railing, and start light kitchen activities. Swelling around the knee is at its worst around day 4–5. Ice and elevation matter more than people think. Most patients can stop the strongest pain medication by day 7.

Week 2–4 (rebuilding). Physical therapy moves from passive range-of-motion to active strengthening. By week 3 most patients are walking with a cane, not a walker. Driving usually resumes around week 4 for right-knee surgery (left-knee patients with automatic transmission can drive sooner). Light desk work is realistic by week 3.

Week 5–8 (regaining normal). Cane is set aside. Stairs are easier. Long walks (30+ minutes) are comfortable. Most patients report 75–80% of pre-surgery function. You'll still have a 'good leg' and 'bad leg' awareness — that's normal.

Week 9–12 (consolidating). The knee starts to feel like yours again. Swimming, cycling, light hikes are all on the table. Most office workers are back full-time. The 90-day mark is when we do the next clinical check and most patients are discharged from active physiotherapy.

What's NOT realistic in 90 days: full kneeling without discomfort (that takes 6–12 months for many patients), running on hard surfaces (we generally discourage it permanently), and complete absence of swelling after long days (mild end-of-day swelling can persist for 6 months).

The single biggest predictor of good recovery is consistency with physiotherapy in weeks 2–6. Patients who attend every session and do their home exercises daily recover faster, more completely, and with fewer complications than patients who don't. The surgery is 50% of the outcome; what you do in the next 90 days is the other 50%.

Implant manufacturers like Zimmer, Stryker, DePuy and Smith & Nephew each offer multiple knee designs — cruciate-retaining, posterior-stabilised, ultra-congruent, medial-pivot. The differences are real but small. What matters far more is matching the implant to the patient, not the patient to the implant.

Three patient factors drive the choice. Bone quality — for patients with osteoporosis or poor bone stock we lean towards stemmed or cemented implants for better fixation. Activity expectations — a 55-year-old who wants to keep playing tennis benefits from a more constrained design that tolerates pivoting loads. A 75-year-old aiming to walk comfortably to the temple needs reliability and longevity over performance. Body weight — heavier patients put more load through the implant, so we favour bearings rated for higher cycle counts.

Two anatomical factors then refine the choice. Cruciate ligament condition: if the posterior cruciate is healthy we can preserve it with a CR design; if it's worn or unreliable we move to a PS design that compensates with implant geometry. Patellar tracking history: patients with prior patellar problems sometimes benefit from a more anatomic trochlear groove.

What patients should ASK their surgeon — not what brand, but what reasoning. "Why this specific implant for me?" If the answer is "this is what we use" without patient-specific reasoning, you're getting a one-size-fits-all approach. The right answer should reference your bone quality, your activity goals, and your specific anatomy.

Finally, implant warranties matter less than implant track record. A 5-year warranty on a poorly-designed implant is worse than no warranty on one with 25 years of published outcome data behind it. Ask about the published 10-year survivorship rate for the specific implant your surgeon recommends.

1. Precision of bone cuts. A robotic system plans the cuts to within 0.5 mm. A skilled manual surgeon achieves about 2–3 mm. That difference compounds across the four cuts needed for a knee replacement and shows up as better alignment in the final result.

2. Soft-tissue balancing. The robot uses real-time tension feedback to balance the ligaments around your knee. With manual technique we balance by feel and experience — good surgeons do this well, but the robot does it consistently.

3. Pre-operative planning. Robotic systems build a 3D model of YOUR knee from a CT scan before surgery, so we know the exact implant size and position before the first cut. Manual technique relies on intra-operative measurements with templates.

4. Operative time. Robotic adds about 15 minutes per case. In return, you get the precision benefits above. Most patients consider that a fair trade.

5. Pain and recovery. Studies — and our own outcome data — show robotic patients report less early post-op pain because of the smaller soft-tissue disruption. The difference narrows by week 6 but matters most in week 1.

6. Implant longevity. Better alignment means less uneven wear on the implant. Long-term studies suggest robotic placements may last 2–3 years longer on average. For a 60-year-old patient that can be the difference between needing a revision at 78 vs 81.

7. Cost. Robotic costs more, sometimes ₹50,000–₹1,00,000 above manual. It's not the right choice for every patient — straightforward knees in younger patients often do beautifully with manual technique. The cost is most justified for complex deformity cases, bilateral surgeries, or patients with active lifestyle expectations.

The honest summary: robotic is a tool, not magic. In the hands of an experienced surgeon doing 1,500+ cases a year, it adds real value. In hands without that volume, it's an expensive crutch. Ask your surgeon about their case volume before deciding.

It combines three things. First, careful pre-operative planning using imaging and patient-specific implants, so the cuts are smaller and more precise. Second, tranexamic acid administered at the right point in the operation, which reduces fibrinolysis (the body's natural breakdown of clots that holds bleeding in check). Third, meticulous intra-operative haemostasis — sealing bleeders as we go rather than dealing with them at the end. The result, across the 35,000+ joint replacements I've done in 23 years of practice, is that most Zero-Technique patients never need a transfusion at all.

Why does this matter to you as a patient? Three reasons. Recovery is faster because your body isn't simultaneously healing from surgery and rebuilding its blood supply. Hospital stay is shorter — most Zero-Technique patients go home in 3–4 days instead of 5–7. And the risks tied to transfusion (infection, immune reaction, the rare but real complications of donor blood) simply don't apply.

Zero-Technique is not a marketing term. It's a deliberate combination of robotic precision, modern pharmacology, and surgical discipline — applied the same way every single time. If you're considering a knee replacement, ask your surgeon two questions: what's their average blood loss per case, and what percentage of their patients need transfusions. The answers should reassure you, or they should help you decide where to seek your second opinion.